Story perspectives

Tech Entrepreneur Creates Life-Saving mRNA Vaccine for Dog

3/17/2026

Summary

Story summary

Paul Conyngham, Australian tech entrepreneur, developed a personalized mRNA cancer vaccine for his dog Rosie.
Rosie was diagnosed with aggressive mast cell cancer in 2024; conventional treatments failed.
Conyngham used AI tools, including Chat Generative Pre-trained Transformer (ChatGPT) and AlphaFold, to analyze Rosie’s genetic data and identify mutations.
Researchers from University of New South Wales collaborated to create the vaccine, which reduced tumor size by 50%–75% and improved Rosie’s life.

History

Historical Context

In 1995, researchers at the University of Pennsylvania pioneered the first mRNA vaccine, laying the groundwork for innovative treatments against diseases like cancer. This technology evolved significantly, with the first human clinical trials for mRNA cancer vaccines starting in 2001. Today, advancements in mRNA vaccines, such as those developed for COVID-19, highlight their potential to revolutionize both veterinary and human medicine.

1 of 2

Story summary

Paul Conyngham, Australian tech entrepreneur, developed a personalized mRNA cancer vaccine for his dog Rosie.
Rosie was diagnosed with aggressive mast cell cancer in 2024; conventional treatments failed.
Conyngham used AI tools, including Chat Generative Pre-trained Transformer (ChatGPT) and AlphaFold, to analyze Rosie’s genetic data and identify mutations.
Researchers from University of New South Wales collaborated to create the vaccine, which reduced tumor size by 50%–75% and improved Rosie’s life.

1 / 2